Marcia Belvin, SVP, Chief Scientific Officer: CytomX Therapeutics CTMX Sell · Filed 24/03/21

Trade details

Type: Insider sale
Amount: $26,741.55
Shares · price: 12,795 sh · $2.09 a share
Held after: 168,579 sh
Stock: CytomX Therapeutics CTMX
Person: Marcia BelvinSVP, Chief Scientific Officer
Trade date: 24/03/19
Filed: 24/03/21
Days to filing: 2 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/18~24/04/18

Marcia Belvin's recent trades

Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$202.2K
31,492 sh
$202.2K
Filed 03/19
Traded 03/17
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$37.3K
13,884 sh
$37.3K
Filed 25/06/17
Traded 25/06/16
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$11.7K
19,512 sh
$11.7K
Filed 25/03/20
Traded 25/03/18
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20

Marcia Belvin, Chief Officer — sold $26.7K of CytomX Therapeutics CTMX · 7.1% of holdings | Whalegun